Reaction Details Report a problem with these data
Target
Bromodomain-containing protein 2 [91-163]
Ligand
BDBM313789
Substrate
n/a
Meas. Tech.
Binding Assay
IC50
<100±n/a nM
Citation
 Burns, C; Garnier, J; Sharp, PP; Feutrill, J; Cuzzupe, A Benzodiazepines as bromodomain inhibitors US Patent  US10167292 Publication Date 1/1/2019 
Target
Name:
Bromodomain-containing protein 2 [91-163]
Synonyms:
BRD2 | BRD2_HUMAN | Bromodomain-containing protein 2 (BRD2)(BD1) | Bromodomain-containing protein 2 Bromo 1 domain(BRD2 BD1) | KIAA9001 | RING3
Type:
n/a
Mol. Mass.:
8836.08
Organism:
Homo sapiens (Human)
Description:
BD1 (91-163 aa) of P25440
Residue:
73
Sequence:
WKHQFAWPFRQPVDAVKLGLPDYHKIIKQPMDMGTIKRRLENNYYWAASECMQDFNTMFTNCYIYNKPTDDIV
  
Inhibitor
Name:
BDBM313789
Synonyms:
US10167292, Example 33
Type:
Small organic molecule
Emp. Form.:
C26H23ClFN5O
Mol. Mass.:
475.945
SMILES:
C[C@H](NC(=O)c1ccc2-c3c(C)nnn3CCN(c3ccc(Cl)cc3)c2c1)c1ccc(F)cc1 |r|
Structure:
Search PDB for entries with ligand similarity: